In vivo tracking of ¹¹¹In-oxine labeled mesenchymal stem cells following infusion in patients with advanced cirrhosis

详细信息    查看全文

• 作者：Ali Gholamrezanezhad^a ;   ; ^{agholam1@jhmi.edu} ; Sahar Mirpour^a ; Mohammad Bagheri^b ; Mehdi Mohamadnejad^b ; Kamran Alimoghaddam^c ; Leila Abdolahzadeh^b ; Mohsen Saghari^a ; Reza Malekzadeh^b
• 关键词：¹¹¹In-oxine ; Mesenchymal stem cell ; Cirrhosis
• 刊名：Nuclear Medicine and Biology
• 出版年：2011
• 出版时间：October 2011
• 年：2011
• 卷：38
• 期：7
• 页码：961-967
• 全文大小：337 K

文摘

Background

Several animal and few human studies suggest the beneficial role of bone marrow mesenchymal stem cells (MSCs) in liver cirrhosis. However, little is known about the fate of MSCs after infusion in cirrhotic patients. We evaluated stem cell biodistribution after peripheral infusion of MSCs in four cirrhotic patients.

Methods

After three passages of MSCs, the patients received a total of 250?00¡Á10⁶ cells, of which only 50 % of the cells were labeled. Specific activities of 0.21?.67 MBq/10⁶ cells were maintained for the injected labeled MSCs. Planar whole-body acquisitions (anterior/posterior projections) were acquired immediately following infusion as well as at 2 h, 4 h, 6 h, 24 h, 48 h, 7th and 10th days after cell infusion.

Results

After intravenous infusion, the radioactivity was first observed to accumulate in the lungs. During the following hours to days, the radioactivity gradually increased in the liver and spleen, with spleen uptake exceeding that in the liver in all patients. Region-of-interest analysis showed that the percentage of cells homing to the liver (following decay and background corrections and geometric mean calculation) increased from 0.0 % -2.8 % at immediately post-infusion images to 13.0?7.4 % in 10th-day post-infusion. Similarly, the residual activities in the spleen increased from 2.0 % -10.2 % at immediately post-infusion images to 30.1 % -42.2 % in 10th-day post-infusion. During the same period, the residual activities in the lungs decreased from 27.0?3.5 % to 2.0?.4 % .

Conclusion

The infusion of MSCs labeled with ¹¹¹In-oxine through a peripheral vein is safe in cirrhosis. Cell labeling with ¹¹¹In-oxine is a suitable method for tracking MSC distribution after infusion.